ABSTRACT

Bioavailability of Irbesartan (IRB) is only 60% due to its poor aqueous solubility and dissolution rate. Irbesartan (IRB) is an angiotensin II receptor antagonist used in the treatment of hypertension. It delay progression of diabetic nephropathy and also indicated for the reduction of renal disease progression in patients with type II diabetes, hypertension and micro albumin urea or protein urea. According to BCS classification IRB belongs to class II. The aim for present paper to increased the Solubility of IRB by hydrotropic solid dispersion technique which is supposed to improve oral bioavailability. Mixed hydrotropic solid dispersions of IRB were prepared using various hydrotropic agents (Sodium Salicylate, Urea, Niacimide, Sodium Citrate and Sodium alginate) in different ratios. The dissolvability of chose plans was assessed after a preliminary of actual solvency investigation of all the Solid scattering. The examination has been made by evaluating the dissolvability of a medication in the individual hydrotropic specialist and afterward with blends of a hydrotropic specialist. Different hydrotropic specialists were utilized separately in fluctuating convergences of 5%w/v to 40%w/v. The shake cup strategy was utilized to portray the dissolvability of medication pre and post-blended Hydrotropy application. The strong scattering is ready by dissolvable dissipation method. Strong scattering has been portrayed by an instrumental concentrate like XRD (D8 Advanced model of Brukar Axs Company in the 30-800 2 Theta scale) FTIR Shimadzu (IR Prestige 21). The outcomes so acquired were characteristic of dissolvability upgrade of Irbesartan in the mix of a hydrotropic mix than that of individual hydrotropic specialist focus. Hydrotropic solubilization of ineffectively solvent medications utilizing non-micelle-creating substances is a compelling, non-poisonous and green innovation. Keywords: Bioavailability, Mixed hydrotropy, Solubility enhancement, Irbesartan
Publication date: 01/12/2021

https://ijbpas.com/pdf/2021/December/MS_IJBPAS_2021_DEC_SPCL_2016.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2021/10.12.2016